McKesson Co. (NYSE:MCK) Director Susan R. Salka Sells 606 Shares

McKesson Co. (NYSE:MCK - Get Free Report) Director Susan R. Salka sold 606 shares of the business's stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $558.04, for a total transaction of $338,172.24. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Susan R. Salka also recently made the following trade(s):

• On Monday, May 13th, Susan R. Salka sold 1 shares of McKesson stock. The shares were sold at an average price of $554.61, for a total transaction of $554.61.

McKesson Price Performance

Shares of NYSE:MCK traded down $3.03 during midday trading on Tuesday, reaching $551.58. The company had a trading volume of 550,696 shares, compared to its average volume of 713,992. The stock has a market capitalization of $71.70 billion, a P/E ratio of 24.65, a PEG ratio of 1.32 and a beta of 0.45. McKesson Co. has a one year low of $373.28 and a one year high of $566.01. The stock's fifty day moving average price is $533.33 and its 200-day moving average price is $496.67.

McKesson (NYSE:MCK - Get Free Report) last announced its quarterly earnings results on Tuesday, May 7th. The company reported $6.18 earnings per share for the quarter, missing analysts' consensus estimates of $6.34 by ($0.16). The company had revenue of $76.36 billion for the quarter, compared to analyst estimates of $79.32 billion. McKesson had a negative return on equity of 245.88% and a net margin of 0.97%. The firm's revenue for the quarter was up 10.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $7.19 earnings per share. As a group, sell-side analysts forecast that McKesson Co. will post 31.55 earnings per share for the current year.

McKesson Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, July 1st. Stockholders of record on Monday, June 3rd will be issued a dividend of $0.62 per share. The ex-dividend date is Monday, June 3rd. This represents a $2.48 dividend on an annualized basis and a dividend yield of 0.45%. McKesson's dividend payout ratio (DPR) is presently 11.08%.

Institutional Investors Weigh In On McKesson

A number of hedge funds have recently made changes to their positions in MCK. Norges Bank bought a new stake in shares of McKesson during the fourth quarter valued at approximately $1,024,140,000. International Assets Investment Management LLC raised its holdings in McKesson by 1,044.5% during the fourth quarter. International Assets Investment Management LLC now owns 821,262 shares of the company's stock worth $380,228,000 after purchasing an additional 749,504 shares in the last quarter. Massachusetts Financial Services Co. MA raised its holdings in McKesson by 16.0% during the third quarter. Massachusetts Financial Services Co. MA now owns 5,148,794 shares of the company's stock worth $2,238,953,000 after purchasing an additional 708,438 shares in the last quarter. TD Asset Management Inc raised its holdings in McKesson by 202.8% during the fourth quarter. TD Asset Management Inc now owns 602,138 shares of the company's stock worth $278,778,000 after purchasing an additional 403,312 shares in the last quarter. Finally, Bessemer Group Inc. raised its holdings in McKesson by 3,621.7% during the first quarter. Bessemer Group Inc. now owns 349,395 shares of the company's stock worth $187,572,000 after purchasing an additional 340,007 shares in the last quarter. Institutional investors own 85.07% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the stock. Morgan Stanley boosted their target price on shares of McKesson from $522.00 to $548.00 and gave the company an "overweight" rating in a report on Monday, April 15th. Barclays boosted their price target on shares of McKesson from $571.00 to $596.00 and gave the company an "overweight" rating in a research note on Wednesday, May 8th. Deutsche Bank Aktiengesellschaft reduced their price target on shares of McKesson from $547.00 to $545.00 and set a "buy" rating on the stock in a research note on Thursday, May 9th. Leerink Partnrs reiterated an "outperform" rating on shares of McKesson in a research note on Monday, February 26th. Finally, Argus increased their price target on shares of McKesson from $510.00 to $570.00 and gave the stock a "buy" rating in a research note on Wednesday, April 10th. Two investment analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, McKesson presently has an average rating of "Moderate Buy" and an average target price of $571.47.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.